Inventor · disambiguated record
Kevin G. Liu
Also filed as: LIU KEVIN · LIU KEVIN G · LIU KEVIN GUANGCHENG
19 granted patents·8 pending applications·64 citations·filing 2001–2024
91Inventor score
Top patents by PatentIndex Score
27 records- 0193US10696660B2Rho kinase inhibitorsKADMON CORP LLC·Filed 2019·Granted Jun 30, 2020·17 cites·3 claims
- 0293US10183931B2Rho kinase inhibitorsKADMON CORP LLC·Filed 2017·Granted Jan 22, 2019·18 cites·9 claims
- 0392US9815820B2Rho kinase inhibitorsKADMON CORP LLC·Filed 2013·Granted Nov 14, 2017·22 cites·14 claims
- 0484US11602559B2HIV-1 Env fusion peptide immunogens and their useUS HEALTH·Filed 2017·Granted Mar 14, 2023·2 cites·16 claims
- 0581US11071735B2Treatment of inflammatory conditions and autoimmune diseases with glucose uptake inhibitorsKADMON CORP LLC·Filed 2018·Granted Jul 27, 2021·2 cites·36 claims
- 0678US12458691B2HIV-1 ENV fusion peptide immunogens and their useUS HEALTH·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 0772US7501421B2Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Mar 10, 2009·1 cites·20 claims
- 0870US7723329B2Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH LLC·Filed 2006·Granted May 25, 2010·1 cites·22 claims
- 0970US2024360085A1Glucose Uptake InhibitorsKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 1069US11479533B2Inhibitors of Rho associated coiled-coil containing protein kinaseKADMON CORP LLC·Filed 2018·Granted Oct 25, 2022·1 cites·20 claims
- 1169US2024190827A1Inhibitors of Rho Associated Coiled-Coil Containing Protein KinaseKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 1266US2023174519A1Inhibitors of Rho Associated Coiled-Coil Containing Protein KinaseKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 1366US2021147391A1Rho kinase inhibitorsKADMON CORP LLC·Filed 2020·Application pending·0 cites
- 1459US10988484B2Glucose uptake inhibitorsKADMON CORP LLC·Filed 2019·Granted Apr 27, 2021·0 cites·7 claims
- 1559US7482461B2Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Jan 27, 2009·0 cites·12 claims
- 1659US2009105303A1Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2008·Application pending·0 cites
- 1759US2025101436A1Aptamers and small molecule ligandsMEIRAGTX UK II LTD·Filed 2022·Application pending·0 cites
- 1855US12030857B2Glucose uptake inhibitorsKADMON CORP LLC·Filed 2019·Granted Jul 9, 2024·0 cites·2 claims
- 1955US11926596B2Inhibitors of Rho associated coiled-coil containing protein kinaseKADMON CORP LLC·Filed 2018·Granted Mar 12, 2024·0 cites·18 claims
- 2055US2009318470A11-substituted-3-(naphthalen-1-ylsulfonyl)-5-(piperazin-1-yl)-1h-indazole compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2009·Application pending·0 cites
- 2154US11613531B2Inhibitors of RHO associated coiled-coil containing protein kinaseKADMON CORP LLC·Filed 2018·Granted Mar 28, 2023·0 cites·17 claims
- 2253US10273248B2Glucose uptake inhibitorsKADMON CORP LLC·Filed 2016·Granted Apr 30, 2019·0 cites·16 claims
- 2347US2007281922A11-Sulfonylindazolylamine and - amide derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Application pending·0 cites
- 2446US10125144B2Rho kinase inhibitorsKADMON CORP LLC·Filed 2014·Granted Nov 13, 2018·0 cites·8 claims
- 2545US7790751B2Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH LLC·Filed 2006·Granted Sep 7, 2010·0 cites·14 claims
- 2641US7141591B21,2,4-oxadiazole derivatives as hPPAR alpha agonistsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Nov 28, 2006·0 cites·15 claims
- 2733US10729691B2Treatment of infectious diseases with glucose uptake inhibitorsKADMON CORP LLC·Filed 2016·Granted Aug 4, 2020·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →